Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes

Title
Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes
Authors
Keywords
Peroxisome proliferator activated receptors, PPARs, Adipocytes, Metabolic syndrome, Obesity, Type 2 diabetes, Inflammation
Journal
PHARMACOLOGICAL RESEARCH
Volume 107, Issue -, Pages 125-136
Publisher
Elsevier BV
Online
2016-03-12
DOI
10.1016/j.phrs.2016.02.027

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More